FIELD: pharmaceuticals.
SUBSTANCE: invention relates to new morpholinylpyridone compounds of formula (I), pharmaceutical compositions and methods of using such compounds in the treatment of diseases, including breast cancer, bladder cancer, liver cancer, cervical cancer, pancreatic cancer, leukemia, lymphoma, kidney cancer, colon cancer, glioma, prostate cancer, ovarian cancer, melanoma and lung cancer, as well as hypoxic tumors.
EFFECT: new compounds of morpholinylpyridones of formula (I) with properties of Vps34 inhibitors have been obtained.
30 cl, 2 tbl, 37 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 6-HETEROCYCLYL-4-MORPHOLINE-4-ILPYRIDINE-2-ONES SUITABLE FOR THE TREATMENT OF CANCER AND DIABETES | 2017 |
|
RU2762968C2 |
| 6-ARYL-4-MORPHOLINE-1-YL PYRIDONES SUITABLE FOR TREATMENT OF CANCER OR DIABETES | 2017 |
|
RU2754664C2 |
| PYRIDINAMINPYRIDONES AND PYRIMIDINAMINPYRIDONES | 2018 |
|
RU2804638C2 |
| AZAINDOLYL PYRIDONE AND DIAZAINDOLYL PYRIDONE | 2018 |
|
RU2788659C2 |
| PYRIDYLPYRIDONES | 2018 |
|
RU2805334C2 |
| PYRROLO[2,1-f][1,2,4]TRIAZINE COMPOUND, METHOD FOR PRODUCTION AND USE THEREOF | 2013 |
|
RU2589053C1 |
| DIFLUOROMETHYLAMINOPYRIDINES AND DIFLUOROMETHYLAMINOPYRIMIDINES | 2015 |
|
RU2712091C2 |
| COMPOUNDS TARGETING TAU PROTEIN AND RELATED USE THEREOF | 2017 |
|
RU2805523C2 |
| PYRIDOPYRIMIDINONE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2818954C1 |
| CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS CONTAINING THEM | 2018 |
|
RU2795146C2 |
